N/A
N=739
Impact of Sperm DNA Integrity on In Vitro Cycles
Male Infertility · Unexplained Infertility · Abortion, Habitual
Bottom Line
View on ClinicalTrials.gov: NCT01232465 ↗Enrolled (actual)
739
Serious AEs
—
Results posted
Mar 2014
Primary outcome: Primary: Pregnancy — 67; 80 participants
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- —
- Age
- Pediatric, Adult, Older Adult
- Sex
- Male
- Sponsor
- Northwell Health
- Primary completion
- Feb 2013
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pregnancy |
67; 80 | — |
Summary
Sperm DNA integrity will be measured via the Toluidine Blue Assay (TBA) for patients undergoing In Vitro Fertilization (IVF); the study will determine correlations, if any, between IVF success and sperm DNA integrity.
Eligibility Criteria
Inclusion Criteria
- couple undergoing IVF at the Center for Human Reproduction
- sperm sample given from partner (not a donor)
Exclusion Criteria
- low sperm concentration (<5 million/cc)
- using a donor sample
Data sourced from ClinicalTrials.gov (NCT01232465). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.